Beverage capable of resisting blood coagulation and making method of beverage

Abstract

The invention discloses a beverage capable of resisting blood coagulation and a making method of the beverage. The beverage capable of resisting blood coagulation comprises the following raw materialsin parts by weight: 10-15 parts of radix gentiana manshurica Kitag. or radix gentiana scabra Bunge. or radix gentiana triflora pall. or radix gentiana rigescens Franch., 3-8 parts of radix astragali,1-2 parts of radix salviae miltiorrhizae, 4-6 parts of Chinese wolfberry fruits, 3-5 parts of root of great burdock, 5-8 parts of licorice roots, 0.5-1 part of honey, 1-3 parts of maltooligosaccharides and 1-3 parts of rosemary herb. According to the beverage capable of resisting blood coagulation disclosed by the invention, a radix gentiana manshurica Kitag. or radix gentiana scabra Bunge. or radix gentiana triflora pall. or radix gentiana rigescens Franch. extract has favorable effect of resisting blood coagulation, the radix astragali is mainly used for invigorating vigor and strengtheningthe body resistance and can improve the immune functions of organisms, the radix salviae miltiorrhizae can promote blood circulation, remove blood stasis, nourish blood and soothe the nerves, and rich soluble protein and the like in the honey, great burdock root oligosaccharide and an gloeostereum incarnatum extraction solution are used as assistance, so that the beverage integrates nutrition andhealth-care functions.

Description

technical field [0001] The invention belongs to the technical field of food and drink, and in particular relates to an anticoagulant drink and a preparation method thereof. Background technique [0002] With the improvement of living standards, people's requirements for beverages are no longer limited to quenching thirst and refreshing, but also require high nutritional value. Anticoagulant drinks occupy a certain market in dietary life due to their better health effects. [0003] With the improvement of people's living standards and changes in diet structure, cardiovascular and cerebrovascular diseases have become the main cause of death after cancer. Most patients with thrombosis require anticoagulant drinks during surgery. Heparin is the most common anticoagulant beverage drug used in clinical treatment, and plays a very important role in the treatment of the above diseases. However, most of the production of heparin comes from animal organs, which may carry pathogenic...

AI Technical Summary

Problems solved by technology

However, most of the production of heparin comes from animal organs, which may carry pathogenic microorganisms, animal allergens, and pyrogens, which may cause harm to human health

In addition, the use of heparin is often accompanied by some side effects such as: easy to cause bleeding, hyperkalemia, heparin-induced thrombocytopenia, etc.